Home > Advice Column, Ethicator > The Ethicator: It’s not Personal, is it?

The Ethicator: It’s not Personal, is it?

April 26th, 2011

Invisible ManDear Ethicator,

I am thinking about jumping on the bandwagon and nominating you for the PharmaVoice 100. With the deadline (May 1) fast approaching, I must confess that I still have some reservations about you as a candidate. Don’t get me wrong:  I think you’re brilliant and all, but at times, your attacks on your brother seem, well,  a little personal. Is it really ethical for you to set up a website attacking your brother on a daily basis? Help me out here.



Dear Queasy,

I am deeply dismayed that you would threaten my academic freedom by posing a question like this.  As most of my readers know, the White Coat, Black Hat website is not meant as an indictment of any particular individual. Instead, it’s intended as a forum attempt to address, as a matter of policy, the problem  of cheapskate fuckers who steal their brother’s ideas and turn them into hate-speech infested polemics against hardworking pharma patriots.

The issue raises lot of  questions that merit further study.  For example: Is it appropriate for a so-called bioethicist to exploit his brother’s goodwill and force him to work for free? Are others in the field obliged to speak out in defense of the victimized younger brother? I’m just putting the question out there; nothing personal.  Also, if the brother decides to go online with his concerns and suddenly becomes an online viral sensation, well, what then? Is the plagiarizing fucker expected to take it like a grown-up, or is he entitled to whine like a baby and maybe sue? It’s a question of professionalism and academic integrity, for which some high-level discussions may be necessary.

I hope this clears matters up for you. Remember: 5 more days until the PharmaVoice 100 deadline!

The Ethicator

Got a moral question you just can’t solve?  Send it to the Ethicator: info@whitecoatblackhat.com

Advice Column, Ethicator

  1. No comments yet.
  1. No trackbacks yet.